Discovery of Actions, so far Unknown, of DPP-4 Inhibitors, a Drug for Diabetes
[July 21,2016] It is discovered that DPP-4 (dipeptidyl peptidase-4) inhibitors, most frequently used for treatment of diabetes in Japan, exert the actions, so far unknown, to attenuate obesity-induced inflammation of adipose tissues and insulin resistance.